Artigo científico · 2022
Persistently positive SARS-CoV-2-specific IgM during 1-year follow-up
Dear Editor, Immunoglobulin M (IgM) antibodies typically appear in the early stageof infection and have a short maintenance time, so IgM is frequentlyused as a diagnostic criterion for acute or recent disease.1However,unconventional IgM‐specific responses have been described in SARS‐CoV‐2 infection, raising doubts Ver mais
Síntese em português
Resumo
Dear Editor, Immunoglobulin M (IgM) antibodies typically appear in the early stageof infection and have a short maintenance time, so IgM is frequentlyused as a diagnostic criterion for acute or recent disease.1However,unconventional IgM‐specific responses have been described in SARS‐CoV‐2 infection, raising doubts about the use of IgM as a biomarkerfor COVID‐19 and the role of this antibody in immunity to SARS‐CoV‐2
Como referenciar
Referência da publicação original
ABNT (NBR 6023)
FONSECA, MARCELA H. G.; et al. Persistently positive SARS-CoV-2-specific IgM during 1-year follow-up. JOURNAL OF MEDICAL VIROLOGY, [s. l.], 2022. DOI: https://doi.org/10.1002/jmv.27822. Disponível em: https://doi.org/10.1002/jmv.27822. Acesso em: 6 de outubro de 2026.
LaTeX / BibTeX
@article{g2022persistentlypositivesarscov2specific,
author = {FONSECA, MARCELA H. G. and SILVA, MARIA F. S. and PINTO, ANA C. M. D. and MELO, AMANDA C. L. and OLIVEIRA, FÁTIMA DE C. E. and ARAÚJO, FERNANDA M. DE C. and ANDRADE, LUIZ O. M.},
title = {Persistently positive SARS-CoV-2-specific IgM during 1-year follow-up},
year = {2022},
journal = {JOURNAL OF MEDICAL VIROLOGY},
doi = {10.1002/jmv.27822},
url = {https://doi.org/10.1002/jmv.27822}
}
Os dados bibliográficos descrevem a publicação original indicada nesta página; o LARIISA funciona como acervo de acesso.